IQVIA™ Real-World Insights Bibliography

Persistence with Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in Germany
Author(s): Kostev K, Kap EJ
Affiliations(s): IQVIA, Frankfurt am Main, Germany
Publication(s): 
Document Type(s): Abstract,
Countries: Germany,
C:
Y:
Medication compliance, Mental health,
2018
  L:
A:
English
Database Study, Epidemiological study,
  Add to report
 
 
The Impact of Risk Minimization Measures on Compliance and Prescribing Practices of Flupirtine in Germany.
Author(s): Kaplan S, Ehlken B, Hamann X
Affiliations(s): Teva Pharmaceutical Industries Ltd , Petach Tikva , Israel. IQVIA (formerly IMS Health) , Munich , Germany. Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany
Publication(s):  Curr Med Res Opin
Document Type(s): Article,
Countries: Germany,
C:
Y:
Drug Utlization Study, Medication compliance,
2018
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions
Author(s): Catherine Collet(1) – Anne de Saunière (1) – Dominique Perrot (2) – Isabelle Bardoulat (2)
Affiliations(s): (1) ARS Ile de France, Paris, France – (2) Quintiles IMS, Paris, France
Publication(s):  Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
Document Type(s): Poster,
Countries: France,
C:
Y:
Diabetes, Medication compliance,
2017
  L:
A:
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis,
  Add to report
 
 
Impact of A Pharmacist Medication Adherence Consultation Program on Health Care Costs and Risk of Hospitalization
Author(s): Wade R.L.1, Hill J.W.1, Akinbosoye O.2, Jiang Z.2, Mu Y.2, Sun K.1, Karkare S3, Taitel M.S.2
Affiliations(s): 1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health,Deerfield, IL, USA
Publication(s):  VALUE IN HEALTH. 2015. 18(3):A3
Document Type(s): Podium presentation,
Countries: USA,
Click here for the abstract
C:
Y:
Medication compliance,
2017
  L:
A:
English
Retrospective database analysis, Survey research,
  Add to report
 
 
L’observance médicamenteuse des patients diabétiques de type 2 en île-de-france : état des lieux et priorités d’actions [Drug adherence in patients with type 2 diabetes in Île-de-France: state of play and priorities for action].
Author(s): Bardoulat I1, Chauvin F1, De Saunière A2, Le Jeunne P1, Perrot D1, Collet C2
Affiliations(s): 1 QuintilesIMS, La Défense, France 2 ARS ÃŽle-de-France, Paris, France
Publication(s):  9ème Colloque données de santé en vie réelle / AFCROs (Cité Universitaire, Paris, 13 juin 2017)
Document Type(s): Oral presentation,
Countries: France,
C:
Y:
Diabetes, Medication compliance,
2017
  L:
A:
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis,
  Add to report
 
 
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions [Drug adherence in patients with type II diabetes in the Île-de-France region: study results and priorities for action].
Author(s): Collet C1, De Saunière A1, Perrot D2, Bardoulat I2
Affiliations(s): 1 ARS Ile de France, Paris, France 2 Quintiles IMS, Paris, France
Publication(s):  Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
Document Type(s): Poster,
Countries: France,
C:
Y:
Diabetes, Medication compliance,
2017
  L:
A:
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis,
  Add to report
 
 
METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE
Author(s): Harmand S, El Mouaddin N
Affiliations(s): IMS Health France
Publication(s):  19th ISPOR COngress 2016
Document Type(s): Abstract, Poster,
Countries: France,
C:
Y:
Medication compliance, Methodology,
2016
  L:
A:
English
Compliance, Database Study, Methodology,
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Dermatology Results from the COMPANION Study
Author(s): Shear N1,2, Bessette L3, Marshall JK4, Lebovic G5,6, Gerega S7, Millson B7, Gaetano T8, Gazel S8, Latour M8, Laliberté MC8
Affiliations(s): 1 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 2 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada; 4Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 IMS Brogan, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s):  Dermatology Update 2016 Annual Meeting, November 3-6, Montreal, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Dermatology, Medication compliance,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations(s): 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publication(s):  American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Medication compliance,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6
Affiliations(s): 1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s):  American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Medication compliance, Rheumatology,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
 1 of 5 Next Page Last Page